sulfathiazole has been researched along with Hepatitis B Virus Infection in 1 studies
Sulfathiazole: A sulfathiazole compound that is used as a short-acting anti-infective agent. It is no longer commonly used systemically due to its toxicity, but may still be applied topically in combination with other drugs for the treatment of vaginal and skin infections, and is still used in veterinary medicine.
sulfathiazole : A 1,3-thiazole compound having a 4-aminobenzenesulfonamido group at the 2-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Usmanova, LP | 1 |
| Kasimova, NB | 1 |
| Kuznetsova, TA | 1 |
| Kotel'nikova, LI | 1 |
| Bogdanova, AG | 1 |
| Cherenova, OP | 1 |
1 other study available for sulfathiazole and Hepatitis B Virus Infection
| Article | Year |
|---|---|
[The effect of the acetylation phenotype on the course severity and outcome of acute viral hepatitis B].
Topics: Acetylation; Acute Disease; Adolescent; Adult; Hepatitis B; Hepatitis B Surface Antigens; Humans; Mi | 1996 |